A Simple Array Platform for MicroRNA Analysis and Its Application in Mouse Tissues by Tang, Xiaoqing et al.
University of Kentucky
UKnowledge
Plant and Soil Sciences Faculty Publications Plant and Soil Sciences
10-2007
A Simple Array Platform for MicroRNA Analysis
and Its Application in Mouse Tissues
Xiaoqing Tang
University of Kentucky
Jozsef Gal
University of Kentucky, jgal2@uky.edu
Xun Zhuang
University of Kentucky, xunzhuang@uky.edu
Wang-Xia Wang
University of Kentucky, wwangc@uky.edu
Haining Zhu
University of Kentucky, haining@uky.edu
See next page for additional authors
Right click to open a feedback form in a new tab to let us know how this document benefits you.
Follow this and additional works at: https://uknowledge.uky.edu/pss_facpub
Part of the Biochemistry Commons, Molecular Biology Commons, Plant Sciences Commons,
and the Soil Science Commons
This Article is brought to you for free and open access by the Plant and Soil Sciences at UKnowledge. It has been accepted for inclusion in Plant and
Soil Sciences Faculty Publications by an authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu.
Repository Citation
Tang, Xiaoqing; Gal, Jozsef; Zhuang, Xun; Wang, Wang-Xia; Zhu, Haining; and Tang, Guiliang, "A Simple Array Platform for
MicroRNA Analysis and Its Application in Mouse Tissues" (2007). Plant and Soil Sciences Faculty Publications. 101.
https://uknowledge.uky.edu/pss_facpub/101
Authors
Xiaoqing Tang, Jozsef Gal, Xun Zhuang, Wang-Xia Wang, Haining Zhu, and Guiliang Tang
A Simple Array Platform for MicroRNA Analysis and Its Application in Mouse Tissues
Notes/Citation Information
Published in RNA, v. 13, issue 10, p. 1803-1822.
Copyright © 2007 RNA Society
The copyright holder has granted the permission for posting the article here.
Digital Object Identifier (DOI)
https://doi.org/10.1261/rna.498607
This article is available at UKnowledge: https://uknowledge.uky.edu/pss_facpub/101
METHOD
A simple array platform for microRNA analysis
and its application in mouse tissues
XIAOQING TANG,1 JOZSEF GAL,2 XUN ZHUANG,1 WANGXIA WANG,1 HAINING ZHU,2
and GUILIANG TANG1
1Gene Suppression Laboratory, Department of Plant and Soil Sciences and Kentucky Tobacco Research and Development Center,
University of Kentucky, Lexington, Kentucky 40546-0236, USA
2Department of Molecular and Cellular Biochemistry, University of Kentucky College of Medicine, Lexington,
Kentucky 40536-0509, USA
ABSTRACT
MicroRNAs (miRNAs) are a novel class of small noncoding RNAs that regulate gene expression at the post-transcriptional level
and play a critical role in many important biological processes. Most miRNAs are conserved between humans and mice, which
makes it possible to analyze their expressions with a set of selected array probes. Here, we report a simple array platform that
can detect 553 nonredundant miRNAs encompassing the entire set of miRNAs for humans and mice. The platform features
carefully selected and designed probes with optimized hybridization parameters. Potential cross-reaction between mature
miRNAs and their precursors was investigated. The array platform was used to analyze miRNAs in the mouse central nervous
system (CNS, spinal cord and brain), and two other non-CNS organs (liver and heart). Two types of miRNAs, differentially
expressed organ/tissue-associated miRNAs and ubiquitously expressed miRNAs, were detected in the array analysis. In addition
to the previously reported neuron-related miR-124a, liver-related miR-122a, and muscle-related miR-133a, we also detected
new tissue-associated miRNAs (e.g., liver-associated miR-194). Interestingly, while the majority of pre-miRNAs were
undetectable, miR690, miR709, and miR720 were clearly detected at both mature and precursor levels by the array analysis,
indicating a limited cross-reaction between pre-miRNAs and their mature miRNAs. The reliability of this array technology was
validated by comparing the results with independent Northern blot analyses and published data. A new approach of data
normalization based on Northern blot analysis of one ubiquitously expressed miRNA is introduced and compared with
traditional approaches. We expect this miRNA array platform to be useful for a wide variety of biological studies.
Keywords: miRNA; miRNA array; pre-miRNA; miRNA biogenesis; miRNA array normalization; central nervous system (CNS)
INTRODUCTION
MicroRNAs (miRNAs) are recently discovered, abundant
small noncoding RNAs that regulate gene expression at the
post-transcriptional level (Lai 2003; Nelson et al. 2003;
Ambros 2004; Bartel 2004; He and Hannon 2004; Du and
Zamore 2005; Berezikov et al. 2006; Nilsen 2007). These
small RNA molecules are highly conserved among organ-
isms in both the animal and the plant kingdoms and play
critical roles in many important biological processes,
including developmental timing (Horvitz et al. 1983;
Ambros 1989; Liu et al. 1995; Rougvie and Ambros 1995;
Euling and Ambros 1996; Moss et al. 1997; Slack and
Ruvkun 1997; Reinhart et al. 2000), neuronal cell fate
(Sempere et al. 2004; Johnston et al. 2005; Vo et al. 2005; Li
et al. 2006a), apoptosis (Cheng et al. 2005; Cimmino et al.
2005; Tanno et al. 2005; Jovanovic and Hengartner 2006;
Thompson and Cohen 2006), proliferation (Brennecke et al.
2003; Hayashita et al. 2005; Lee et al. 2005; Chen et al.
2006; Costinean et al. 2006; Hossain et al. 2006; Hwang and
Mendell 2006; Thompson and Cohen 2006), hematopoiesis
(Chen et al. 2004; Chen and Lodish 2005; Kluiver et al.
2006; Min and Chen 2006; Ramkissoon et al. 2006; Yu et al.
2006), cancer development (Iorio et al. 2005; Jiang et al.
2005; Akao et al. 2006; Garzon et al. 2006; Lee et al. 2006; Li
et al. 2006b; Mattie et al. 2006; Saito et al. 2006; Silveri et al.
2006; Volinia et al. 2006; Yanaihara et al. 2006), neurolog-
ical disorders (Ding et al. 2005; Mehler and Mattick 2006),
insulin secretion or exocytosis of the secretory pathway
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(Mello and Czech 2004; Poy et al. 2004; Cuellar and
McManus 2005; Gauthier and Wollheim 2006; Plaisance
et al. 2006), B-cell development (Calin et al. 2004; Costinean
et al. 2006), and adipocyte differentiation (Esau et al.
2004; Kajimoto et al. 2006). More than 4500 miRNAs have
been identified from 44 organisms and annotated in the
miRBase registry (http://microrna.sanger.ac.uk) (Griffiths-
Jones 2006; Griffiths-Jones et al. 2006). From these, 475,
377, and 234 miRNAs have been identified in humans,
mice, and rats, respectively (Griffiths-Jones 2006; Griffiths-
Jones et al. 2006). Bioinformatics analysis predicts that
miRNAs comprise z5% of the transcriptome (Bentwich
2005), and may regulate the translation of more than one-
third of human mRNA species (Lewis et al. 2005). An addi-
tional independent analysis predicted that 20% of human
genes can potentially be regulated by miRNAs (Xie et al.
2005). One challenge is how to effectively measure the
expression of miRNA genes.
The expression levels of individual miRNAs can be
determined by quantitative Northern blot analysis (Tang
et al. 2003; Tang and Zamore 2004). Northern blot analysis
has the advantage of simultaneously detecting the mature
miRNAs and miRNA precursors, but it is a very labor-
intensive approach. As a result, a number of different
miRNA array platforms have been developed (Krichevsky
et al. 2003; Babak et al. 2004; Calin et al. 2004; Liu et al.
2004; Nelson et al. 2004; Sempere et al. 2004; Sioud and
Rosok 2004; Jiang et al. 2005; Liang et al. 2005; Lim et al.
2005; Monticelli et al. 2005; Shingara et al. 2005; Castoldi
et al. 2006; Grundhoff et al. 2006; Lee et al. 2006; Mattie et al.
2006; Tang et al. 2006; Wang and Wang 2006; Zhao et al.
2006; Wang et al. 2007). The earliest prototype array for
miRNA expression using isotope labeling was straightfor-
ward (Krichevsky et al. 2003). This miRNA array platform
was further pursued (Monticelli et al. 2005), but not widely
applied due to insufficient optimization with respect to
various controls, probe repeats, and the related titration.
In contrast, many nonisotope miRNA array platforms have
been developed and commercialized. These miRNA array
systems have played an essential role in identifying miRNAs
that are important for normal development as well as
various human diseases (Calin et al. 2005; Monticelli et al.
2005; Watanabe et al. 2005; Wienholds et al. 2005; Calin
and Croce 2006; Cummins and Velculescu 2006; Davison
et al. 2006; Kim et al. 2006; Martin et al. 2006; Murakami
et al. 2006; Nelson et al. 2006; Pallante et al. 2006; Song and
Tuan 2006; Thomson et al. 2006; Weber et al. 2006; Weston
et al. 2006; Yanaihara et al. 2006).
Unlike array analysis for mRNA expression, miRNA
arrays typically involve a complicated procedure due to
the small size of miRNAs and the lack of a conserved 39 end
for easy sample labeling. These complicated steps include
the ligation of RNA adapters to the miRNAs, RT–PCR
amplification, and T7 RNA polymerase transcription
(Nelson et al. 2004; Davison et al. 2006). The current non-
isotope miRNA array platforms are still expensive and
require special skills. Furthermore, the complicated array
steps often lead to process-related systematic biases that are
inherent to RNA ligation or PCR amplification (Davison
et al. 2006). To simplify these steps, we have systematically
optimized the conditions for an earlier version of an
isotope-labeled miRNA array platform (Krichevsky et al.
2003; Monticelli et al. 2005), and further developed this
system demonstrating its use in mouse miRNA analysis. A
total of 553 probes were used in this array platform that can
detect all annotated miRNAs of humans and mice. This opti-
mized isotope array platform is simple, cost-effective, easy-
to-use, high throughput, highly sensitive, and can be easily
adapted and utilized for a wide variety of biological studies.
RESULTS
Overall design of a simple miRNA array
and its rationale
Our objective in the design of the array system was to
provide a simple, cost-effective, and high-throughput plat-
form that could be easily adopted in most laboratories. Thus,
the overall design of the array platform includes: (1)
selecting unique miRNAs for probe design to reduce
potential cross-hybridization between different probes; (2)
optimizing the probe concentration and specificity; (3)
isolating mature miRNAs (z22 nucleotides [nt]) to avoid
the interference of signals from pre-miRNAs (z70 nt); (4)
directly labeling the isolated small RNAs to avoid using
adaptors and biased amplification of the miRNAs; (5)
introducing a new way of data normalization by using a
Northern blot analysis of a constitutively expressed miRNA
for initial data adjustment; and (6) introducing a set of
external controls for evaluation of process-related loss of
signals and quantification of endogenous miRNAs. We
used the sensitive isotope 32P to label the small RNAs and
nylon membranes for miRNA array analysis to visualize the
array results and exclude the nonintuitive results generated
from the numeric data of the background. The overall
design of the miRNA array platform is outlined in Figure 1.
Selection of miRNAs for probe design
More than 820 miRNAs have been cloned or predicted
from humans and mice (Griffiths-Jones 2006; Griffiths-
Jones et al. 2006). These miRNAs are divided into different
families and some family members (paralogs) only differ by
a few nucleotides. Thus, cross-hybridization between the
miRNAs and their probes is inevitable. To evaluate the
extent of cross-hybridization and to design unique probes
that reduce cross-hybridization, we designed and synthe-
sized 22 DNA probes (21 nt): one wild type and the others
with a single nucleotide difference from the wild type
(Fig. 2A). The 22 DNA probes (0.25 pmol/each) were spotted
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and immobilized on a membrane by UV cross-linking, and
then were hybridized with a radiolabeled synthetic RNA
oligo that complements all of these DNA probes. The
concentration of the labeled RNA oligo was z0.1 pmol,
reflecting the upper-limit concentration of endogenous
miRNAs in our array platform. The results showed that a
21-nt synthetic RNA that has 18–19 consecutive nucleotides
complementary to the probes had a cross-hybridization
effect (Fig. 2B). Thus, probes for miRNAs that have less
than 18–19 consecutive identical nucleotides were designed
and synthesized. For example (Table 1),
among the human miRNA let-7 family
members, let-7a has 18 consecutive
nucleotides identical to let-7c. There-
fore, either let-7a or let-7c, but not both,
would be a candidate for probe design
and synthesis. The reason for such
selection is that the probe for let-7a
cannot distinguish between let-7a and
let-7c and vice versa. Other let-7 para-
logs, 7b, 7d, 7e, 7f, 7g, and 7i, will all be
selected for probe synthesis, because
those let-7 members have less than 18
identical nucleotides in an 18-nt region.
We chose paralogous miRNAs that
have less than 18 consecutive identical
nucleotides for probe design and syn-
thesis, based on the data of single
nucleotide difference experiments (Fig.
2). To date, 847 human and mouse
miRNAs, including species conserved,
species specific, and identical members
of certain miRNA families (Supple-
mental Table S1), have been annotated
and deposited at the miRBase (http://
microrna.sanger.ac.uk/). Using the above criteria, 553 miRNAs
are eligible for probe design and synthesis. These miRNA
probes can detect all annotated human and mouse miRNAs
as well as miRNAs from other animal sources (Supple-
mental Table S2).
Probe concentration titration for array spotting
at a linear range
Nonredundant probes (which, as described above, are
predicted to not cross-react with each other) were UV
FIGURE 1. A scheme of the miRNA array platform. The array design included probe design
and specificity titration, external control design and titration, probe spotting, sample
preparation, array hybridization, Northern blot analysis for one constitutively expressed
miRNA and U6/5S rRNA for initial data normalization, and array normalization and
comparison. (Qpix2) A spotting robot; (MAC) miRNA array control; (MAS) miRNA array
specificity; (AP) Antarctic phosphatase; (PNK) polynucleotide kinase.
FIGURE 2. Specificity of single nucleotide differences in miRNA array. (A) The probe sequences of 22 specificity controls. Probe #1 is 100%
complementary to the labeled RNA. The others (Probe #2–22) hybridize to the labeled RNA with only a single nucleotide difference at different
positions. (B) The labeled RNA was hybridized to the membrane that was spotted in duplicate with the control probes. The array results showed
high specificity at the level of a single nucleotide difference.
microRNA Profiling
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cross-linked onto the nylon membrane and hybridization
between the probes and isolated miRNAs was performed in
a similar fashion as in traditional Northern blot analysis. A
total of 553 selected DNA oligonucleotide probes were
synthesized by Integrated DNA Technologies (IDT). Sub-
sequently, we determined how much miRNA probes should
be spotted on the array using a high-throughput robot,
Qpix2, at the Advanced Genetic Technologies Center
(AGTC) of the University of Kentucky. We chose three
miRNAs that were expressed at high, medium, and low
levels, respectively. Their DNA probes were diluted at
different concentrations (80, 40, 20, and 10 mM, respec-
tively). These serially diluted probes were printed onto the
membrane with one, two, three, four, five, and six prints
(each print takes z3 nL of the probe) on each spot. Isolated
small RNAs were labeled and hybridized to the membrane
for titration. Results indicated that three prints (z9 nL
total) of 20-mM probes gave the best array results within
the linear range (data not shown).
miRNA array detection range
and systematic normalization probes
To test the miRNA array linear range
for quantification, we designed and
synthesized five different synthetic
RNA oligos that were different in their
sequences to serve as miRNA array
controls (MACs) (Fig. 3A). Five MAC
probes (MAC1P, MAC2P, MAC3P,
MAC4P, and MAC5P), which corre-
sponded to the five synthetic RNA
oligos (MAC1, MAC2, MAC3, MAC4,
and MAC5) were synthesized and
printed on the array membrane at the
same concentration (0.25 pmol) as that
of the miRNA array probes (Fig. 3A).
Different amounts (5, 10, 20, 40, and
60 fmol) of the five synthetic RNA oligos
were used to mix with each sample RNA
before small RNA isolation and labeling
with [g-32P]ATP and PNK, followed by
a hybridization analysis. Results from
this analysis (Fig. 3B) demonstrated that
the array signals accurately reflected
the amount of input of the synthetic
RNA oligos in a linear range, indicating
that the array platform is highly
reliable.
miRNA array probe duplicate
printing and UV cross-linking
Based on the above probe concentration
optimization experiments, 0.2 pmol of each of the 553
miRNA probes were printed in duplicate. The array map
was designed in a 32 row 3 18 column format so that the
553 probes in duplicate could be spotted in a reasonable
area to detect high, medium, and low levels of endogenous
miRNAs simultaneously, as well as for easy quantification.
Each pair of probe duplicates was arranged vertically inside
a square of the array. The five external control probes
(MAC1, MAC2, MAC3, MAC4, and MAC5) were
also included at the lower-left corner of the array for
array system normalization (Table 2). To generate array
membranes in high quantity and with high quality, the
553 miRNA probes and the five external control probes
of the above-designed array were spotted in duplicate
onto Hybond N membranes by using the Genetix Qpix2
robot. After probe printing, the spotted membranes were
wetted in 2X SSPE and the probes were permanently
linked to the membrane by UV cross-linking. The efficiency
TABLE 1. Selection criteria for miRNA probe synthesis
human let-7
family miRNA sequences Probe selection?
hsa-let-7c UGAGGUAGUAGGUUGUAUGGUU Yes
hsa-let-7a UGAGGUAGUAGGUUGUAUAGUU No, 18 nt identical to 7a
with no gap
hsa-let-7b UGAGGUAGUAGGUUGUGUGGUU Yes, less than 18 nt identical
hsa-let-7d AGAGGUAGUAGGUUGCAUAGU Yes, less than 18 nt identical
hsa-let-7e UGAGGUAGGAGGUUGUAUAGU Yes, less than 18 nt identical
hsa-let-7f UGAGGUAGUAGAUUGUAUAGUU Yes, less than 18 nt identical
hsa-let-7g UGAGGUAGUAGUUUGUACAGU Yes, less than 18 nt identical
hsa-let-7i UGAGGUAGUAGUUUGUGCUGU Yes, less than 18 nt identical
FIGURE 3. Detection range of miRNA array. (A) The sequences for the quantification and
titration RNA oligoss (MAC1, MAC2, MAC3, MAC4, and MAC5) and their correspond-
ing DNA probes (MAC1P, MAC2P, MAC3P, MAC4P, and MAC5P). (B) The detection
range analysis. The mixture of synthetic RNAs (MAC1–5) with different amounts (5–60 fmol)
were radiolabeled and hybridized to the membrane that was spotted with the same amounts
(0.25 pmol) of the five DNA probes. The range of 5–60 fmol of synthetic RNA reflects the
array linear range that is the average amount of most endogenous miRNAs in our preliminary
array analysis.
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and reliability of the cross-linking have been verified by the
stable array results using the stripped membranes for many
times without a decrease of miRNA detecting ability.
miRNA array analysis of mouse CNS
and non-CNS organs/tissues
We applied the array platform to analyze mouse miRNAs
in two CNS (brain and spinal cord) and two non-CNS
(liver and heart) tissues. Small RNAs (15–28 nt) were
isolated from the total RNAs of mouse brain, spinal cord,
liver, and heart using a 15% urea– polyacrylamide gel
electrophoresis (PAGE) sequencing gel. These small RNAs
were dephosphorylated with Antarctic phosphatase (AP,
New England Biolabs) and then labeled with [g-32P]ATP
and polynucleotide kinase (PNK). These radiolabeled small
RNAs were hybridized with the miRNA membrane array
and subsequently detected using a PhosphorImager
(Typhoon 9400, Amersham). The rep-
resentative array images are shown in
Figure 4.
A total of 148 unique miRNAs were
detectable in the four tissues altogether
and they are summarized in Table 3.
For an easy description, the 148 unique
miRNAs were divided into two catego-
ries: tissue-specific and tissue-shared-
specific miRNAs. Tissue-specific miRNAs
are those that were only expressed in
one of the arrayed tissues, while the
tissue-shared-specific miRNAs were
conserved in two or more tissues and
are only detectable in these tissues. The
tissue-shared-specific miRNAs were
further divided into several subcatego-
ries according to their expression pat-
terns among different tissues. Among
the 148 unique miRNAs, 112, 93, 44,
and 114 miRNAs were detected in the
mouse brain, spinal cord, liver, and
heart, respectively, and 36 miRNAs were
ubiquitously expressed in all of the four
arrayed organs. The 36 ubiquitous
miRNAs include let-7b, let-7c, let-7d,
let-7e, let-7f, miR17-5p, miR21, miR22,
miR23b, miR24, miR26a, miR30a-5p,
miR30c, miR30d, miR92, miR99a,
miR103, H-miR106a, M-miR106a,
miR107, miR125b, miR143, miR145,
miR191, miR222, miR296, miR320,
miR324-3p, miR361, miR423, miR484,
miR486, miR652, miR690, miR709 (this
one was determined by Northern blot;
see cross-reaction between mature
miRNAs and their precursors below),
and miR720. The expression levels of the 36 ubiquitous
miRNAs varied among tissues.
There are 18 miRNAs specifically expressed in both brain
and spinal cord (defined as ‘‘CNS-specific’’): miR34a,
miR129, miR129-3p, miR212, miR298, miR300, miR326,
miR330, miR346, miR370, miR381, miR383, miR409-3p,
miR431, miR433, miR485-5p, miR487b, and miR541.
Furthermore, the brain showed its own tissue-specific
miRNAs: miR-9, miR-96, miR-134, miR-331, miR-341,
miR-344, miR-409-5p, miR-434-3p, miR-485-3p, miR-491,
miR-532, and miR-543, while the spinal cord showed no
tissue-specific miRNA of its own (Table 3; Fig. 4A). MiR-
124a was the most abundant in the mouse brain and spinal
cord, which is in agreement with previous array results
(Krichevsky et al. 2003; Saba and Booth 2006). MiR-124a was
previously considered as neuron-specific miRNA. However,
our array data showed that a low level of miR-124a was also
expressed in the heart (Fig. 4D). Thus, the miR-124a is
FIGURE 4. An array analysis of miRNA global expression in mouse CNS and non-CNS
tissues. Total RNA (50 mg) from mouse brain, spinal cord, liver, and heart was separated on a
15% PAGE and 15–28 nt small RNAs were isolated from the gel and treated for the array as
described in the Materials and Methods. Of the four organs, CNS, spinal cord (A) and brain
(B), contain the most abundant miRNAs. Liver (C) contains the lowest number of miRNAs of
the four organs. Heart (D) also contains abundant miRNAs. The five external array controls
(MAC1–5) are located at the bottom row on the right.
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categorized as one of 32 ‘‘CNS-heart-shared’’-specific
miRNAs as shown in Table 3 and Supplemental Figure S1.
Among the 44 liver-expressed miRNAs (Table 3, Note 1),
only three (miR192, miR215, and miR194), were liver
specific. The specific expression of miR194 was further
validated in this study (see the Northern blot validation
section). Liver showed an expression of fewer miRNAs than
other arrayed tissues. Liver also showed less shared-specific
miRNAs with other arrayed tissues (Table 3).
There were 114 miRNAs expressed in the mouse heart
(Table 3, Note 1). Among them, 25 were heart specific:
miR-1, miR-15a, miR-15b, miR-27a, miR-27b, miR-29b,
miR-29c, miR-31, miR-32, miR-208, miR-210, miR-339,
miR-365, miR-373*, miR-378, miR-451, miR-487a, miR-
488, miR-493-3p, miR-496, miR-499, miR-504, miR-513,
miR-612, miR-689, and miR-714 (Table 3). MiR-133a, a
muscle-enriched miRNA, is highly expressed in the mouse
heart. This miRNA was also expressed in the CNS, and thus
categorized into CNS heart-shared-specific miRNAs (Table
3). A detailed analysis of miRNAs for their organ specificity
and conservation among two, three, or four mouse organs
is provided in Table 3 and Supplemental Figure S1.
As shown in Table 3 and Supplemental Figure S1, the
brain and spinal cord are the most similar, sharing 87
miRNAs, with 18 miRNAs expressed specifically. Interest-
ingly, the heart not only expresses as many as 114 miRNAs,
but also shares many miRNAs with the
brain (81 miRNAs) and the spinal cord
(74 miRNAs). In contrast, the liver
shares much fewer common or shared-
specific miRNAs with the CNS than
the heart, with no specific miRNAs
shared with brain or spinal cord alone
(Supplemental Fig. S1).
Northern validation of the miRNA
array results
Our miRNA array is based on DNA
(array-based probe printed on mem-
brane)–RNA (miRNA labeled in solu-
tion) hybridization, which is different
from the traditional Northern blot tech-
nique of labeling the DNA probe (in
solution). To confirm that the array
results are reliable, we chose miRNAs
with low, medium, and high abundan-
ces and validated the array results
independently using Northern blot
techniques. The array and Northern
blot validation data are shown in
Figure 5. MiR-124a is considered to be
a brain-specific miRNA (Conaco et al.
2006), but we found that miR-124a was
not only expressed at high levels in
brain tissue, but also was expressed at high levels in the
spinal cord (Figs. 4A, 5A). Interestingly, miR-124a was also
detectable at very low levels in the heart by our array
analysis (Fig. 4D), but was not apparent by the Northern
blotting analysis (Fig. 5A). This might be due to the lower
sensitivity of Northern blotting or an inaccurate processing
of the mature miR-124a in this tissue (see the Discussion
section). MiR-222, which was reported to be detected in
blood (Marsit et al. 2006), was expressed in brain tissues
with medium abundance (Fig. 5B). MiR-122a was thought
to be a ‘‘liver-specific’’ miRNA with high abundance
(Chang et al. 2004; Jopling et al. 2005; Krutzfeldt et al.
2005), but we found it to be detectable in the heart
(Fig. 5C). MiR-194 was expressed in the liver with low
abundance (Fig. 5D). MiR-133a (Fig. 5E) and miR-486
(Fig. 5F) were both clearly detected in the heart with
medium abundance. The array data are all in excellent
agreement with the Northern blot results, indicating that
the miRNA array technology is reliable, highly sensitive,
and accurate.
Cross-reaction between mature miRNAs
and their precursors
The biogenesis of miRNAs is a process of multistep
reactions (Lee et al. 2002, 2003). Long primary transcripts
FIGURE 5. Northern blot validation of some tissue-associated miRNAs. Total RNA (10 mg
per sample) from mouse spinal cord, brain, liver, and heart were electrophoresed in 15%
polyacrylamide gels under denaturing conditions, blotted, and hybridized with 32P-labeled
miRNA probes. 5S rRNA stained with ethidium bromide was used for loading control. U6
(light blue column) or 5S rRNA (purple column) was used for normalization separately and
the signal corresponding to the miRNA with the highest signal intensity was set to 100. The
expression patterns of miR-124a (A), miR-222 (B), miR-122a (C), miR-194 (D), miR-133a (E),
and miR-486 (F) were consistent with the array data. The array bar was exported individually
from the clustering tree (see Fig.8). Red indicates positive signal and black indicates no signal
in the array.
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(pri-miRNAs) are first processed into short miRNA pre-
cursors (pre-miRNAs) by Drosha complex in the nucleus
(Han et al. 2004). Pre-miRNAs are transported into
cytoplasm, where mature miRNAs of z22 nt are generated
by Dicer (Lee et al. 2002, 2003; Yi et al. 2003; Lund et al.
2004). Only mature miRNAs are the active players that
are assembled into effecter complexes or RISCs. Thus, it
is important for an array platform to detect only the levels
of mature miRNAs without a cross-reaction with pre-
miRNAs. To prevent such cross-reactions, we specifically
isolated small RNAs of 15–28 nt using a 15% sequencing
gel in our array analysis. Since pre-miRNAs are generally in
stem–loop structures, they may not be able to unwind and
hybridize with the array probes. However, the stem region
of the pre-miRNAs generally contains mismatches or
bulges that destabilize the stem region, making it possible
to form a relatively stable base pairing between the probes
and the pre-miRNAs. This consequently may lead to a
cross-reaction between the probes and the pre-miRNAs. To
evaluate the extent of such cross-reactions, we specifically
isolated RNAs of z60–200 nt, contain-
ing enriched pre-miRNAs, using a 15%
sequencing gel, and subjected these
longer RNAs to the array analysis. Three
pre-miRNAs, pre-miR-690, pre-miR-709,
and pre-miR-720, were able to cross-
react with their miRNA probes. Pre-
miR-594 also showed a cross-reaction
signal in the array analysis. However,
miR-594 was recently found to be
from a tRNA (Helvik et al. 2007) and
excluded from the bona fide miRNA
category (Fig. 6A).
To evaluate the abundance of these
pre-miRNAs and their mature miRNAs,
we conducted a Northern blot analysis
of total RNA from different tissues
using probes that hybridize with these
miRNAs or their precursors. In agree-
ment with the earlier array (Fig. 4) and
Northern blot (Fig. 5) analyses, miR-
122a, miR-124a, and miR-133a showed
robust mature miRNA signals in corre-
sponding tissues, but none or minimal
pre-miRNA signals (Fig. 6B). The
Northern blot analysis of 10 mg of total
RNAs showed significant amounts of
pre-miR-690, pre-miR-709, and pre-
miR-720, but barely detectable signals
corresponding to mature miR-690,
miR-709, and miR-720. Longer expo-
sure images showed a faint broad band
corresponding to each mature miRNA
(Fig. 6B). The relative low abundances
of these mature miRNAs are in contrast
to their robust miRNA signals detected in the array analysis
(Fig. 4). This may be due to the fact that small RNAs were
enriched from greater amounts of total RNAs (50–100 mg)
in the miRNA array analysis. Alternatively, the relative
abundances of pre-miRNAs and their mature miRNAs
detected in this study potentially reveal the difference of
endogenous processing between long primary RNAs to pre-
miRNAs and to mature miRNAs (see more details in the
Discussion section). In conclusion, the majority of pre-
miRNAs is at much lower levels and show no cross-reaction
with miRNA array probes. Isolation of small RNAs (15–28
nt) to exclude the potential cross-reaction of pre-miRNAs,
such as the pre-miRNAs of miR-690, miR-709, and miR-
720, is a safeguard step for specific miRNA array analysis
and proper data interpretation.
Array data adjustment, normalization, and clustering
The raw array data were first corrected by subtracting the
background, adjusted with external and internal controls by
FIGURE 6. Cross-reaction of miRNA precursors with miRNA probes. (A) Array analysis for
mouse spinal cord and mouse brain using 60–200 nt small RNAs. Some miRNA (miR-690,
miR-709, and miR-720) precursors of over 60 nt cross-reacted with miRNA probes (Fig. 4, cf.
A and B). (B) Northern blotting analysis of pre-miR-690, pre-miR-709, and pre-miR-720,
which are highly abundant and cross-react with the probes of their mature miRNAs, and pre-
miR-124a, pre-miR-122a, and pre-miR-133a, which are very little or none and have no cross-
reaction with the probes of their mature miRNAs. Signals from pre-miRNAs are highlighted
by arrows. (Lanes 1,2,3,4) Samples from spinal cord, brain, liver, and heart, respectively.
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Northern blot analysis, and then further processed with
normalization and clustering. Due to the fact that process-
ing-related sample loss occurs differently in different
sample treatments, the same amount of total RNA in
different samples may not give comparable array results.
Thus, an initial data adjustment for different samples is
necessary. Two kinds of initial data adjustment methods
were used: (1) data adjusted with external control RNAs
that were mixed with a fixed amount of total RNA; and (2)
data further adjusted with miRNA let-7b (a constitutively
expressed miRNA) normalized by 5S RNA (Fig. 7A) or U6
RNA (Fig. 7B) using a Northern blot analysis. After data
adjustment, we performed standard data transformation
and clustering analyses using Cluster 3.0. The clustering
data were then visualized using Java TreeView (Fig. 8). The
results showed that the clustering patterns of data adjusted
with external and internal controls were different, indicat-
ing that data adjustment with different approaches affects
array results and interpretation (Fig. 8).
DISCUSSION
Various miRNA array platforms have been developed in the
past four years (Krichevsky et al. 2003; Babak et al. 2004;
Calin et al. 2004; Liu et al. 2004; Nelson et al. 2004;
Sempere et al. 2004; Sioud and Rosok 2004; Jiang et al.
2005; Liang et al. 2005; Lim et al. 2005; Monticelli et al.
2005; Shingara et al. 2005; Castoldi et al. 2006; Grundhoff
et al. 2006; Lee et al. 2006; Mattie et al. 2006; Tang et al.
2006; Wang and Wang 2006; Zhao et al. 2006; Wang et al.
2007). One purpose of this study was to reduce the steps of
small RNA labeling for array hybridization so that the loss
of miRNAs during sample labeling could be minimized. So
far, most miRNA array platforms require many steps
including adding adapters for the isolated small RNAs,
reverse transcription, PCR amplification, and labeling the
RNAs with two dyes via RNA transcription. To reduce the
pitfalls of certain biases introduced by these complex steps,
an RNA-primed, array-based Klenow enzyme (RAKE)
miRNA platform was developed to avoid using adapters
and the amplification step (Nelson et al. 2004). Other
approaches for detecting endogenous miRNAs without
amplification have also been developed using splinted
ligation (Maroney et al. 2007). We developed a similar
strategy to directly label the small RNAs at their 59 end
by introducing radiolabeled phosphates. The radiolabeled
small RNAs were hybridized to membranes containing
arrayed miRNA probes. This is effective because radioactive
signals are highly sensitive and reflect the expression levels
of different miRNAs.
This straightforward miRNA array platform has the
following advantages: (1) high sensitivity: signals from
z100 to 300 ng of the isolated small RNAs can reveal the
lowest level of endogenous miRNAs at the femtomole
range; (2) high specificity: the array can distinguish a single
nucleotide difference; (3) repeatability: the array results
remain identical for the same samples in repeats and in
different experiments of array analysis; (4) cost effective-
ness: it costs less than $100 per dual samples; also, the array
membrane can be stripped and reprobed many times; (5)
simplicity: one can use the array platform without need
of special equipment or software for analysis; (6) reliability:
the miRNA signal reflects the level of in vivo miRNAs
without any signal amplification, thus, the endogenous
levels of miRNAs can be estimated using external linear
controls; and (7) verifiability: results were in very good
agreement with Northern blot analysis because the array
is based on a direct hybridization between endogenous
miRNAs and the miRNA probes on the membrane, which
is virtually a high-throughput technique for Northern blot
analysis. In addition, results from our array analysis of
mouse tissues revealed new findings about miRNA expres-
sions in these tissues. Like many other array platforms, this
array platform has advantages, disadvantages, and unsolved
issues as discussed below.
Probe specificity
A challenge in utilizing microarrays or other hybridization-
based assays is the problem of potential cross-hybridiza-
tion. Nonspecific hybridization often results in artifactual
expression profiles or increased data variance. To estimate
the extent of cross-reaction, we generated a series of 21-mer
DNA probes (22 probes, altogether) with a single nucleo-
tide mutation from position 1 to position 21, counted from
the 59 end (Fig. 2A). The mutated probes were printed on
the membrane and probed with a synthetic RNA oligo that
is complementary to the probes. Results indicate that the
array can distinguish a single nucleotide difference at most
positions except those mutation positions (z2 nt) near the
59 and 39 ends (Fig. 2B). In other words, small RNAs with
19 consecutive identical bases were not distinguishable by
FIGURE 7. Northern blot analysis of let-7b. Total RNA (10 mg per
sample) from mouse spinal cord, brain, liver, and heart were electro-
phoresed in 15% polyacrylamide gels under denaturing conditions,
blotted, and hybridized with 32P-labeled let7b probe. The expression
level of let7b relative to 5S rRNA (A) and U6 (B) were used for
normalization separately. The numbers corresponding to the tissue
with the lowest signal intensity (liver) was set to 100.
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our array system, which was also discussed by Nelson et al.
(2004). To minimize cross-hybridization as much as pos-
sible, we have designed and synthesized probes that have
less than 18 consecutive identical bases for our array plat-
form. The specificity of the probes designed according to
these criteria was demonstrated in the mouse tissue array
analysis. For example, let-7c and let-7e have only a 3 nt
difference, but have less than 18 consecutive identical bases
(Table 1). Probes of let-7c and let-7e can distinguish their
different expression patterns in mouse tissues (Fig. 4).
While let-7c was highly expressed in both spinal cord and
brain tissues, let-7e expressed low in spinal cord (Fig. 4A,
Row 1 and Column 7) and much higher in brain (Fig. 4B,
Row 1 and Column 7). This indicates that probe for let-7c
has little, if any, cross-reaction with let-7e. Similar exam-
ples can be found for many members of other miRNA
families in our study (Fig. 4). Thus, the probes in our array
system can distinguish most, but not all, specific members
of most miRNA families.
To investigate whether the first and last two nucleotides
may drive specificity when probes are shorter, we designed
and synthesized four sets of probes of
different lengths (17–21 mer) (Supple-
mental Fig. S2A) that complement, but
mismatch at the first and the last
nucleotide, with four synthetic RNA
oligos (21 nt). These probes were spot-
ted in duplicate on the membrane
(Supplemental Fig. S2B) and were
hybridized with different amounts (5–
40 fmol) of the four radiolabeled syn-
thetic RNA oligos. The results clearly
show that the first and the last two
nucleotides were not the factors to deter-
mine the hybridization specificity (Sup-
plemental Fig. S2B). No hybridization
signal was detected when the probes were
shorter than 18 mer, which is in agree-
ment with our criteria for probe design.
To further investigate whether vari-
able hybridization conditions, especially
above 37°C, could affect the array spec-
ificity or cross-reactions, we conducted
the miRNA array analysis for mouse
brain tissues at 37°C, 42°C, and 50°C,
respectively. The results demonstrated
that the array specificity has no appar-
ent difference between the conditions of
37°C and 42°C, but array signals were
significantly decreased at 50°C (Sup-
plemental Fig. S3), apparently due to
a reduced binding ability of the small
RNAs to their probes under this tem-
perature condition.
Another important potential source
of cross-reaction is pre-miRNAs that may also hybridize
with miRNA probes when 15–200 nt small RNAs (for
example, small RNAs isolated using the mirVana miRNA
Isolation Kit) are used for array analysis, leading to
incorrect interpretation of the array results. Our array
analysis using RNAs of 60–200 nt revealed that the majority
of, except for a few, miRNAs showed no significant cross-
reaction between mature miRNAs and their precursors
(Fig. 6). In our miRNA array platform, we routinely isolate
small RNAs of 15–28 nt for array analysis, effectively avoiding
such type of cross-reaction.
Sensitivity of the array platform
The traditional method to titrate the amount of specific
miRNAs is quantitative Northern blot analysis (Tang et al.
2003; Tang and Zamore 2004). However, this method is
very labor intensive. In our array platform, no amplifica-
tion was conducted for the endogenous miRNAs and their
levels were thus nicely titrated with the external control
RNAs, with different sequences and linear ranges among
FIGURE 8. Variation of miRNA array clustering introduced by different array normalizations.
(A) About 101 detectable miRNAs were hierarchically clustered based on their expression
profiles in four different organs by using Gene Cluster 3.0 (complete linkage and Euclidean
distance as similarity measure). Data from each miRNA were normalized by different controls
and median centered prior to clustering. Samples are in columns and miRNAs in rows. (B)
Variation of clustering patterns of highlighted miRNAs. (Let-7/U6) Data were normalized by
let-7b level relative to U6 RNA; (Let7/5S) data were normalized by let-7b level relative to 5S
rRNA; (External) data were normalized by external controls; Northern validated miRNAs are
highlighted in red (e.g., H-miR-124a, H-miR-122a, H-miR-133a, H-miR-486, H-miR-222,
H-miR-194). A, B, C, D, and E indicate clustering positions for certain miRNAs or miRNA clusters.
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the different control RNAs. In addition, external control
RNAs at various concentrations (5–60 fmol) were mixed
with 100 mg of total RNAs before gel isolation for small
RNAs. The loss of endogenous small RNAs and the input
external control RNAs have the same probability during the
purification steps and this serves as a titration method for
estimating the actual amount of endogenous miRNAs
expressed in a certain amount of cells or tissues. This is
an important advantage of our microarray platform.
The miRNA-induced silencing complex (miRISC) is a
classical Michaelis–Menten RNA–protein complex enzyme
(Haley and Zamore 2004) that can bind and cleave the
target mRNAs in a multiple turnover manner (Hutvagner
and Zamore 2002). miRISC directed post-transcriptional
regulation depends, to a certain extent, on the amount of
miRISC enzyme. The more miRNA molecules that are in
cells, the more miRISCs are formed, and thus, the more
target mRNAs are regulated. Indeed, currently well-studied
miRNAs are generally the highly expressed miRNAs (Chang
et al. 2004; Jopling et al. 2005; Krutzfeldt et al. 2005; Chen
et al. 2006; Esau et al. 2006; Wang and Wang 2006). The
functions of low-level miRNAs may be in the fine-tuning
regulation of their target genes, and thus, may not be easily
identified. An estimate of the actual amount of the endo-
genous miRNA will thus be an important guideline for the
study of their specific functions.
Although nonradioactive array platforms are generally
preferred, radioactivity still offers one of the most sensitive
approaches for the detection of nonamplified miRNAs, as
shown in our study. We have included five external control
RNAs at the amounts from 5 to 60 fmol (Fig. 4; Table 2,
MAC1–5). Most miRNAs expressed in the analyzed mouse
organs are under 60 fmol (Fig. 4) and the smallest amount
of external control RNA in our array analysis was 5 fmol.
From the actual array results, signals that were weaker than
the 5 fmol external control RNA were still detectable, indi-
cating that our array can successfully detect amounts under
5 fmol with no amplification of endogenous miRNAs.
In addition, small RNAs can be efficiently dephosphory-
lated and rephosphorylated at their 59 end using a phos-
phatase (AP) and a kinase (PNK) (Supplemental Fig. S4),
making it an efficient way to directly label the isolated small
RNAs for array analysis.
Array reliability and Northern blot validation
The reliability of the miRNA array developed in this study
is excellent based on the following observations. First, the
most abundant and tissue-associated mouse miRNAs
revealed in this study are in agreement with previously
published data. For example, our array results showed that
miR-124a was most abundant in CNS tissues and that
miR-122a is an abundant liver-associated miRNA; these
are similar to the previous reports (Jopling et al. 2005;
Krutzfeldt et al. 2005; Esau et al. 2006). Second, Northern
blot validation results were in agreement with the array
results (Fig. 5). Third, clustering analysis of the array results
showed that miRNA expression patterns between the brain
and spinal cord were conserved, reflecting a conservation of
general characteristics of nervous tissues or nerve cells. In
addition, our sensitive array platform revealed new tissue-
associated miRNAs or new locations of the previously
identified miRNAs. For example, miR-486, which is highly
expressed in the heart, has not been reported before. We
also revealed that the brain cells contained a high level of
miR-222, which was identified in the blood (Marsit et al.
2006). It is apparent that our miRNA array platform not
only produces results that are consistent with the literature,
but also generates new data owing to its high sensitivity.
Northern blot validation is traditionally an essential step
for all current miRNA array technologies. In our array
analysis, in addition to traditional approaches for data nor-
malization, we also introduced an additional step for array
data adjustment by Northern blot analysis of a selected
miRNA (let-7b). This additional step may be useful in
determining results from ambiguous array data and give
accurate data interpretation. Since this step is indepen-
dent of the miRNA array process and can be done before
or after the array analysis, it will not affect the efficiency
of the high-throughput array of the samples.
The amount of small RNAs that is isolated from 100 mg
of total RNA is about 5–10 times greater than that from the
amount (10–20 mg) used for Northern blot validation.
Analysis of the external synthetic small RNAs before and
after gel purification estimated that about 95% of the small
RNAs were recovered in the small RNA isolation step. In
our array process, no amplification step was conducted for
the isolated small RNAs, and thus they accurately represent
the endogenous level of small RNAs. In addition, synthetic
miRNA probes (DNA) were printed on the same type
of membrane for Northern blot analysis. Therefore, our
miRNA array platform is essentially a high-throughput
Northern blot analysis. The only difference between our
array analysis and Northern blot is that the Northern blot
technique transfers the small RNA onto the membrane and
DNA probes are labeled for hybridization, while our array
analysis uses the opposite approach with DNA printed on
the membrane and the RNAs labeled for hybridization.
Thus, our array analysis reflects the actual amount of
miRNAs from sampled tissue or cells and is 5–10 times
more sensitive than Northern blot analysis.
Discrepancies sometimes occur between different array
platforms and Northern blot validation for certain miRNAs
(unpublished observations).This may be due to using RNA
adaptors that were not equally ligated to the miRNAs
(Romaniuk et al. 1982; Nelson et al. 2004). Our array
platform avoids the use of adapters in miRNA labeling and
can considerably minimize the discrepancies between array
results and Northern blot validation. Indeed, among the six
selected ubiquitous and tissue-associated miRNAs, Northern
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blot validation results were in extremely high agreement
with our array results. However, low-expressed miRNAs
that can be detected by our array analysis often cannot be
detected by Northern blot analysis (Fig. 5). This is probably
due to the higher sensitivity of our array platform over the
Northern blot analysis. Nevertheless, when we increased the
amount of total RNAs to 100 mg for Northern blot analysis,
the sensitivity of Northern blot analysis was not improved
much. The exact significance of this phenomenon is not
known but may be related to the inability of small amounts
of RNA to be bound to the Northern blot membrane or the
spreading of signals in Northern blots, possibly due to
inaccurate processing of miRNAs in certain tissues.
Array data adjustment, normalization, and controls
Due to their small size, miRNAs are particularly difficult to
analyze by a high-throughput array approach and the array
data normalization is nontrivial (Davison et al. 2006). In
Northern blot analysis, ribosomal RNAs, tRNAs, and U6
are often used as controls for equal loading of total RNAs,
data adjustment, and normalization. However, these con-
trol RNAs are significantly longer than a miRNA, and it is
impossible to probe these control RNAs directly on the
same miRNA array membranes. Many previously reported
miRNA arrays are based on the input amount of total RNA,
assuming that the same amount of total RNA contains
comparable amounts of miRNAs, and that small RNAs
isolated from the same amount of total RNA are recovered
at the same efficiency. Some array platforms use the same
amount of isolated small RNAs as array input and for array
normalization. In our experience, the small RNAs recov-
ered from different samples may vary dramatically after gel
isolation, elution, labeling, and purification. To minimize
the discrepancy between different samples, we designed a
linear range of external control small RNAs. The probes for
these synthetic small RNAs were printed on membranes
side by side with the miRNA probes. The same amount of
the external control RNAs was mixed to each sample of the
same amount before gel isolation so that the fixed amount
of external control RNAs could serve as a control for an
estimation of the loss of miRNAs during small RNA
isolation. In addition, these external controls can serve as
a titration for quantification of endogenous miRNAs.
A theoretically better alternative for adjusting array data
is to use the above-mentioned Northern blot analysis for a
constitutively expressed miRNA normalized by 5S/U6
RNA. For a comparison to the data adjustment by external
controls, we selected the miRNA let-7b that is ubiquitously
expressed in human and mouse organs (Baskerville and
Bartel 2005) as an internal control for Northern blot
analysis using either 5S or U6 RNA for equal sample
loading normalization. Results showed a difference between
the data adjusted by external control RNAs and the data
normalized by an internal let-7b control (Fig. 8), indicating
an influence on data interpretation by different normali-
zation methods. In addition, internal control normalized
by 5S or U6 also produces a different clustering tree. These
differences may be attributed to the variation of 5S or U6
RNAs under different conditions (Fig. 7).
The use of Northern blot analysis of one specific miRNA
in comparison with U6 or 5S RNA for array data
adjustment, rather than only for validation, is a new ad-
ditional way to normalize data in an array analysis. This
normalization is based on the assumption that all the
miRNAs from a specific sample under a specific array have
a relatively stable ratio between total miRNAs and the
proportional loss of miRNAs during purification and
labeling steps. This allows for a reasonable adjusting of
array signals from different samples with one constitutively
expressed miRNA for all the arrayed samples before the
actual array comparison. The disadvantage of this normal-
ization is that all of the arrayed samples must be analyzed
for one miRNA expression level by Northern blot. How-
ever, this step can be done independent of the array process
by the sample providers, and thus will not affect the high-
throughput manner of array analysis. Current miRNA array
platforms use Northern blot analysis only for the validation
of array results. Due to improper normalization, many
miRNA arrays suffer from discrepancies between the array
results and Northern blot analysis (unpublished observa-
tion). An extension of Northern blot analysis for the
miRNA array data adjustment and normalization steps is
helpful for obtaining accurate conclusions.
Although the above technique may be the best possible
method for miRNA array normalization to date, it still
needs additional refinement. We noticed that U6 and 5S
RNA loading controls have different quantitative signals,
indicating that U6 or 5S RNA may also change from sample
to sample (Figs. 5, 7). U6 and 5S RNAs are frequently used
for miRNA arrays and for the validation of results by
Northern blot (Krichevsky et al. 2003; Monticelli et al.
2005; Castoldi et al. 2006; Zhao et al. 2006). These two
control-adjusted data might result in similar results for
some abundant or highly expressed tissue-associated miR-
NAs, but might give different results for miRNAs with
lower expression levels (e.g., see Figs. 5A,D,F, 7), pre-
sumably due to different levels of U6 and 5S RNAs in the
samples. Further investigation of more reliable controls for
miRNA array analysis is needed.
Clustering analysis
Array clustering analysis gives a straightforward compari-
son of similarities and differences between samples. Our
array clustering analyses suggest that the key components
of the mouse CNS (brain and spinal cord) have a highly
conserved miRNA expression pattern, indicating that
neurons in the brain and spinal cord have similar miRNA
characteristics (Figs. 4, 5; Table 3). In addition, our analysis
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showed that the liver and heart are very specialized organs
and retain their unique profiling patterns (Fig. 4; Table 3).
Array clustering analysis is not only important in finding
the differences between different mouse organs, but also in
revealing specific miRNA cohorts that may have specialized
functions. This may be important in identifying miRNA
regulatory networks that are important for specific devel-
opmental processes.
Detection of tissue-specific miRNAs
and their potential functional relevance
We have identified tissue/organ-associated miRNAs in
addition to widely expressed miRNAs. Some tissues express
fewer tissue-specific miRNAs than others (Table 3; Supple-
mental Fig. S1). For example, the liver and spinal cord each
only contain one or zero tissue-specific miRNA. In con-
trast, the brain (12 tissue-specific miRNAs) and the heart
(26 tissue-specific miRNAs) contain much more tissue-
specific miRNAs. In addition, some miRNAs, though not
specifically associated with a particular tissue, are prefer-
entially expressed at high or low levels in certain tissues.
The miRNA expression levels presumably play an impor-
tant role in keeping tissue/organ identity or functions, and
misregulation of them may lead to various kinds of diseases
(Croce and Calin 2005).
No or little miR-195 is expressed in the normal mouse
heart (Fig. 4). It was recently reported that miR-195 is up-
regulated during cardiac hypertrophy (van Rooij et al.
2006). The same study showed that cardiac overexpression
of miR-195 resulted in pathological cardiac growth and
heart failure in transgenic mice, suggesting that misregula-
tion of miR-195 could lead to heart problems. In contrast,
muscle-associated miR-1, which counteracts the role of
miR-195 and inhibits cardiac growth by suppressing the
expression of the basic helix–loop–helix protein Hand2
(Zhao et al. 2005), was specifically expressed in the heart in
our array (Fig. 4; Table 3). This indicates that heart-specific
miRNA, miR-1, plays an important role in heart functions.
Tissue specificity of miRNA expression is probably less
absolute than previously described. MiR-124a, which is
thought to be a brain-specific miRNA (Conaco et al. 2006),
was indeed detected to be the most abundant miRNA in the
mouse brain in our array (Figs. 4B, 5A). In addition, it was
also expressed abundantly in the spinal cord (Figs. 4A, 5A)
and at a low level in the heart (Fig. 4D). Recently, miR-124a
has been shown to be up-regulated in mouse pancreas and
target the transcription factor Foxa2 for regulation of
pancreas development (Baroukh et al. 2007). Another
example is miR-9, which was detected in the mouse brain
in this study (Fig. 4; Table 3). However, it also was reported
as being expressed in pancreatic insulin-secretion cells and
played a negative role in insulin secretion (Plaisance et al.
2006). All of these examples indicate that tissue-specific
miRNAs may not be absolutely tissue specific or function
specific; rather, they may be detectable in other tissues and
have broader roles in gene regulation and function. Extensive
array analysis of different tissue or cell types will certainly
advance miRNA study by revealing their broader functions.
miRNA biogenesis and miRNA array
The miRNA biogenesis is a complex process of multiple
steps and plays an important role in gene regulation by
producing mature miRNAs in a temporal and spatial
manner. A striking observation is that both pre-miRNAs
of miR-690, miR-709, and miR720, and their mature
miRNAs were readily detected by our array analyses (Figs.
4, 6A). Northern blot analysis revealed the presence of a
large amount of these miRNA precursors constitutively
expressed in all of the array mouse tissues. However, their
mature miRNAs are difficult to detect by Northern blot
(Fig. 6B), although robust signals were detected by the
array analysis (Fig. 4). Longer exposed images showed a
faint broad band corresponding to each mature miRNA
(Fig. 6B). These discrepancies raised several questions
regarding the miRNAs to be detected and the reliability
of the array technology.
The precursors of miR-690, miR-709, and miR720 were
the only three miRNA precursors detected in the array
analysis of total RNA (Fig. 6). This indicates that these
miRNAs are probably unconventional endogenous small
RNAs. First of all, the precursors of these miRNAs ac-
cumulated in large amounts in all arrayed tissues (Fig. 6B)
and other cell lines (data not shown). In contrast, in
the case of most miRNAs, only little or no pre-miRNA
accumulates. This suggests that these three miRNAs have a
normal processing of primary miRNAs into pre-miRNAs,
and an abnormal processing of pre-miRNAs into mature
miRNAs. However, whether these accumulated ‘‘pre-miR-
NAs’’ are the product of a Drosha complex is not clear.
Knocking down of Drosha will give insights into the
biogenesis of these ‘‘precursor’’ RNAs.
Second, these three miRNAs (miR690, miR-709, and
miR-720) were previously identified by extensive sequenc-
ing of small RNAs isolated from mouse embryos (Mineno
et al. 2006). They appear ‘‘unconventional’’ by having
longer loops and more mismatches at the ‘‘stem’’ region.
The higher extent of mismatches at the ‘‘stem’’ region may
inhibit the cellular Dicer from effective processing. Addi-
tional cellular factors may be needed for Dicer to process
these miRNA precursors. In certain tissues (e.g., mouse
spleen, testis, and lung), mature miR-690, miR-709, and
miR720 are better processed and a clearer signal of the
mature miRNAs can be detected by Northern blot (Sup-
plemental Fig. S5). It is not clear how these miRNAs are
matured from their precursors and why they are not
effectively processed. Mutation of the ‘‘stem’’ region of
the miRNA precursors for in vitro and in vivo processing
will give insights into the biogenesis of these miRNAs.
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What are those robust array signals for miR-690, miR-
709, and miR720, and why is it difficult to detect them by
Northern blotting? Given that the unconventional second-
ary structures and highly abundant precursors exist to these
miRNAs, the processing of the precursor RNAs by the
Dicer may not be accurate, resulting in a population of
small RNAs with different lengths. This may be the reason
why Northern blot detected no sharp band, rather, a faint
broad band. In contrast, the array signals came from a dot
blot of hybridization between the spotted probes and the
enriched small RNAs. This gives a concentrated signal from
the small RNAs. Finally, the accumulated precursor RNAs
may be subject to degradation, and the degradated prod-
ucts may be enriched in the array hybridization. All of these
possibilities contribute to the discrepancy between the array
and the Northern blot analyses of these miRNAs.
In summary, we have developed a highly sensitive
miRNA array platform and successfully applied it in the
analysis of miRNA profiles in different mouse organs. A
number of new tissue-associated miRNAs have been re-
vealed in different mouse organs. The array platform has
been optimized with various titrations to a linear range.
New methods for data adjustment, normalization, and
clustering analysis have also been introduced to improve
array analysis. This array platform will be widely useful for
various kinds of studies.
MATERIALS AND METHODS
Comprehensive miRNA selection
for the designed array
A total of 553 miRNA probes, which cover the human and mouse-
specific miRNAs, were spotted onto a Hybond N+ membrane by
using the Genetix Qpix2 (Advanced Genetic Technologies Center
at the University of Kentucky). Each array membrane also
contained five quantification and titration probes (MAC1,
MAC2, MAC3, MAC4, MAC5; for detailed probe design and
experimental justification, see the Results section). After being
printed with probes, the membrane was UV cross-linked twice,
with 100 mJ/cm2 for half a minute each time, before and after
rinsing with 2X SSPE.
Sample preparation: Total RNA isolation,
small RNA enrichment, and RNA qualitative
and quantitative assessment
Total RNAs were isolated as previously described using conven-
tional methods (Haley et al. 2003; Tang et al. 2003; Tang and
Zamore 2004), with some modifications for better quality assur-
ance and standardization. Briefly, 4-month-old FVB mice were
anesthetized with an intraperitoneal injection of 0.1 mL Pento-
barbital (50 mg/mL, Abbott Laboratories) and transcardically
perfused with 0.1 M phosphate buffered saline (PBS) (pH 7.5).
Liver, heart, brain, and spinal cord were dissected and snap-frozen
in liquid nitrogen. All animal procedures were approved by the
university IACUC committee. Tissues/organs were frozen in
liquid nitrogen and ground finely with a mortar and pestle. Total
RNAs were extracted using Trizol reagent (Invitrogen) with the
following modification: total RNAs were precipitated with iso-
propanol at –20°C overnight for better precipitation of small
RNAs. RNA quality was examined prior to miRNA isolation using
a Bioanalyzer 2100 (Agilent). An aliquot of total RNA was kept as
a control and for future Northern blot validation.
At least 50 mg of total RNAs from each sample were used for
small RNA (15–28 nt) isolation using 15% denaturing PAGE. A
mixture of synthetic 21-nt control RNAs that were complemen-
tary to five MAC probes were incorporated into each sample (see
details in the Results section). The gel-purified small RNAs were
monitored and quantified by Nanodrop spectrophotometer
(Nanodrop Technologies).
Small RNA labeling and hybridization
of array membrane
The isolated small RNAs were treated with Antarctic Phosphatase
(New England Biolabs) to remove the 59 phosphates. The
phosphatase was heat inactivated and the dephosphorylated small
RNAs were then radiolabeled with [g-32P]ATP and T4 poly-
nucleotide kinase (New England Biolabs). The labeled samples
were purified by passing through a G-25 spin column (Roche) and
monitored for labeling efficiency by analyzing 1 mL of diluted
probes (100 3 dilution) on a 15% sequencing gel. Only well-
labeled samples were used for further hybridization according to
our prior published protocol (Tang et al. 2003; Tang and Zamore
2004).
The arrayed membrane was prehybridized for at least 2 h at
37°C in 50% formamide, 53 SSPE (pH 7.4), 53 Denhardt’s re-
agent, 0.5% SDS, and denatured herring sperm DNA (160 mg/mL).
The radiolabeled small RNAs were then added and allowed
to continue to hybridize overnight. The overnight hybridized
membrane was rinsed and washed three times, 20 min per wash,
at 37°C in 23 SSC and 0.1% SDS. The washed membrane was
then wrapped and exposed on a PhosphorImager screen.
Array quantification and analysis
Signal detection and documentation
The array was scanned using a PhosphorImager scanner
(Typhoon 9400, Molecular Dynamics). Array picture output
and quantification was performed using ImageQuant software
(Amersham Biosciences) and the intensities of duplicate spots on
each array were averaged.
Data normalization
To compare the miRNA expression profiles between different
tissues, external and internal controls were used for array
data normalization. The external controls were used to remove
system-related variations (e.g., amount variations, process-related
loss of small RNAs or signals, variations in labeling signal strength,
and signal gain differences between scanners), so that biologically
relevant variations could be faithfully revealed (see the Results
section) (Quackenbush 2001, 2002; Geller et al. 2003). The
internal control was a ubiquitously expressed miRNA, normalized
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by 5S rRNA or U6. The quantification data with various ways of
normalization are shown in Supplemental Table S3. The selection
of the ubiquitous miRNA was based on a comparison of results
from all arrayed samples.
Clustering analysis
Clustering analyses were performed with a hierarchical method
using an average linkage and Euclidean distance metric to illus-
trate relationships among the data from complex array experi-
ments using Cluster 3.0 (de Hoon et al. 2004). The clustering data
were visualized using Java TreeView (Saldanha 2004).
Northern blot validation
Northern blot analysis was performed as previously described
(Tang et al. 2003; Tang and Zamore 2004). Briefly, 10 mg total
RNA isolated from tissues was run on a denaturing 15% Urea–
PAGE gel, transferred to membrane, blotted, and probed using
DNA oligonucleotides labeled with [g-32P]ATP. Washed North-
ern blots were placed on PhosphorImager screens, scanned sub-
sequently using the Typhoon Scanner, and signals were quantified
using the ImageQuant software package.
SUPPLEMENTAL DATA
All Supplemental Tables can be found at http://www.uky.edu/
zgtang2/publication/RNA-array-method-suppl-data/TableS1-3.xls).
All Supplemental Figures can be found at http://www.uky.edu/
zgtang2/publication/RNA-array-method-suppl-data/Fig-S1-5.pdf.
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